Exane Derivatives’s Huntington Ingalls Industries HII Stock Holding History

Exane Derivatives’s Portfolio HII Stock Details HII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-441	Closed	-$90.8K	–	1062
2021 Q1	$90.8K	Buy	+441	New	+$78.9K	0.03%	432
2020 Q2	–	Sell	-30	Closed	-$5.47K	–	717
2020 Q1	$5.47K	Sell	30 -15,390	-100%	-$3.59M	﹤0.01%	451
2019 Q4	$4.23M	Buy	15,420 +15,411	+171,233%	+$3.65M	0.78%	32
2019 Q3	$1.91K	Hold	9	–	–	﹤0.01%	496
2019 Q2	$2.02K	Hold	9	–	–	﹤0.01%	508
2019 Q1	$1.86K	Hold	9	–	–	﹤0.01%	453
2018 Q4	$1.71K	Sell	9 -12,705	-100%	-$2.76M	﹤0.01%	533
2018 Q3	$3.25M	Buy	+12,714	New	+$3.04M	0.61%	39

Other funds holding HII

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Exane Derivatives's HII Position: Q2 2021 in Review

Exane Derivatives sold out of Huntington Ingalls Industries (HII) in Q2 2021, closing a stake of 441 shares — an estimated $90.8K sold.

Exane Derivatives first reported a position in HII in Q3 2018 and held it in 8 quarters. The position peaked at $4.23M in Q4 2019. 510 funds tracked by Wall St. Rank hold HII as of Q2 2021.

Exane Derivatives reported no remaining Huntington Ingalls Industries position as of Q2 2021 after selling out during the quarter.
Exane Derivatives sold 441 Huntington Ingalls Industries shares in Q2 2021, an estimated $90.8K.
Exane Derivatives first reported a position in Huntington Ingalls Industries in Q3 2018 and held it in 8 quarters.
Exane Derivatives's Huntington Ingalls Industries position peaked at $4.23M in Q4 2019.
510 funds tracked by Wall St. Rank held Huntington Ingalls Industries as of Q2 2021.

Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.